WCM
WST icon

WealthTrak Capital Management’s West Pharmaceutical WST Stock Holding History

WealthTrak Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$219 – 892
2025
Q2 		$219 Buy
+1
New +$214 ﹤0.01% 824
2025
Q1 		– Sell
-3
Closed -$983 – 1124
2024
Q4 		$983 Buy
+3
New +$944 ﹤0.01% 449

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

WealthTrak Capital Management's WST Position: Q3 2025 in Review

WealthTrak Capital Management sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 1 share — an estimated $219 sold.

WealthTrak Capital Management first reported a position in WST in Q4 2024 and held it in 2 quarters. The position peaked at $983 in Q4 2024. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • WealthTrak Capital Management reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 1 West Pharmaceutical share in Q3 2025, an estimated $219.
  • WealthTrak Capital Management first reported a position in West Pharmaceutical in Q4 2024 and held it in 2 quarters.
  • WealthTrak Capital Management's West Pharmaceutical position peaked at $983 in Q4 2024.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on WealthTrak Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.